Preventing foot ulcers in patients with diabetes

JAMA

Volumn 293, Issue 2, 2005, Pages 217-228

  Singh, Nalini ^a,c   Armstrong, David G ^b   Lipsky, Benjamin A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Rosalind Franklin University of Medicine and Science Dr William M Scholl College of Podiatric Medicine   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKLE BRACHIAL INDEX; DEBRIDEMENT; DIABETES MELLITUS; DIABETIC FOOT; DOPPLER FLOWMETRY; FOOT SURGERY; HUMAN; MASS SCREENING; MEDICAL LITERATURE; PATIENT EDUCATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SHOE; SKIN SENSATION; SMOKING CESSATION; TREATMENT OUTCOME; ULCER; VIBRATION SENSE;

EID: 11844293372     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.2.217     Document Type: Review

References (128)

1. Reiber GE. The epidemiology of diabetic foot problems. Diabet Med. 1996;13(suppl 1):S6-S11.
2. Reiber GE. Epidemiology of foot ulcers and amputations in the diabetic foot. In: Bowker JH, Pfeifer MA, eds. The Diabetic Foot. St Louis, Mo: Mosby; 2001:13-32.
3. International Working Group on the Diabetic Foot. Epidemiology of diabetic foot infections in a population-based cohort. Paper presented at: International Consensus on the Diabetic Foot; May 22-24, 2003; Noordwijkerhout, the Netherlands.
4. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26:1435-1438.
5. Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes: 1999-2000 National Health and Nutrition Examination Survey. Diabetes Care. 2004;27:1591-1597.
6. Vileikyte L. Diabetic foot ulcers: a quality of life issue. Diabetes Metab Res Rev. 2001;17:246-249.
7. Meijer JW, Trip J, Jaegers SM, et al. Quality of life in patients with diabetic foot ulcers. Disabil Rehabil. 2001;23:336-340.
8. Vileikyte L, Boulton AJM. Psychological/behavioral issues in diabetic neuropathic foot ulceration. Wounds. 2000;12(6 suppl B):43B-47B.
9. Boulton AJ, Kirsner RS, Vileikyte L. Clinical practice: neuropathic diabetic foot ulcers. W Engl J Med. 2004;351:48-55.
10. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382-387.
11. Tennvall GR, Apelqvist J, Eneroth M. Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomics. 2000;18:225-238.
12. Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyorala K. Lower-extremity amputations in diabetic and nondiabetic patients: a population-based study in eastern Finland. Diabetes Care. 1993;16:16-20.
13. Trautner C, Haastert B, Giani G, Berger M. Incidence of lower limb amputations and diabetes. Diabetes Care. 1996;19:1006-1009.
14. Armstrong DG, Lavery LA, Quebedeaux TL, Walker SC. Surgical morbidity and the risk of amputation due to infected puncture wounds in diabetic versus nondiabetic adults. South Med J. 1997;90:384-389.
15. Cavanagh PR, Boone EY, Plummer DL. The Foot in Diabetes: A Bibliography. College Station: Pennsylvania State University; 2000.
16. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care. 1990;13:513-521.
17. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150-154.
18. Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22:157-162.
19. Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: a prospective study. Diabetes Care. 1994;17:557-560.
20. Sanders LJ. Diabetes mellitus: prevention of amputation. J Am Podiatr Med Assoc. 1994;84:322-328.
21. Zimny S, Schatz H, Pfohl M. The role of limited joint mobility in diabetic patients with an at-risk foot. Diabetes Care. 2004;27:942-946.
22. Fernando DJ, Masson EA, Veves A, Boulton AJ. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care. 1991;14:8-11.
23. Mueller MJ, Hastings M, Commean PK, et al. Forefoot structural predictors of plantar pressures during walking in people with diabetes and peripheral neuropathy. J Biomech. 2003;36:1009-1017.
24. Veves A, Murray HJ, Young MJ, Boulton AJ. The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia. 1992;35:660-663.
25. Macfarlane RM, Jeffcoate WJ. Factors contributing to the presentation of diabetic foot ulcers. Diabet Med. 1997;14:867-870.
26. Maluf KS, Mueller MJ. Novel Award 2002: comparison of physical activity and cumulative plantar tissue stress among subjects with and without diabetes mellitus and a history of recurrent plantar ulcers. Clin Biomech (Bristol, Avon). 2003;18:567-575.
27. American Diabetes Association. Consensus Development Conference on Diabetic Foot Wound Care. Diabetes Care. 1999;22:1354.
28. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia. 2002;45:1011-1016.
29. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259-265.
30. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341:1906-1912.
31. Mayser P, Hensel J, Thoma W, et al. Prevalence of fungal foot infections in patients with diabetes mellitus type 1: underestimation of moccasin-type tinea. Exp Clin Endocrinol Diabetes. 2004;112:264-268.
32. Anarella JJ, Toth C, DeBello JA. Preventing complications in the diabetic patient with toenail onychomycosis. J Am Podiatr Med Assoc. 2001;91:325-328.
33. Gupta AK, Humke S. The prevalence and management of onychomycosis in diabetic patients. Eur J Dermatol. 2000;10:379-384.
34. Chincholikar DA, Pal RB. Study of fungal and bacterial infections of the diabetic foot. Indian J Pathol Microbiol. 2002;45:15-22.
35. Ragnarson Tennvall G, Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications. 2000;14:235-241.
36. Brod M. Quality of life issues in patients with diabetes and lower extremity ulcers: patients and care givers. Qual Life Res. 1998;7:365-372.
37. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer: the Seattle Diabetic Foot Study. Diabetes Care. 1999;22:1036-1042.
38. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med. 1998;158:157-162.
39. Altman MI, Altman KS. The podiatric assessment of the diabetic lower extremity: special considerations. Wounds. 2000;12(6 suppl B):64B-71B.
40. Boike AM, Hall JO. A practical guide for examining and treating the diabetic foot. Cleve Clin J Med. 2002;69:342-348.
41. Armstrong DC, Loss of protective sensation: a practical evidence-based definition. J Foot Ankle Surg. 1999;38:79-80.
42. Armstrong DG. The 10-g monofilament: the diagnostic divining rod for the diabetic foot? Diabetes Care. 2000;23:887.
43. Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care. 2001;24:250-256.
44. Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med. 1998;158:289-292
45. Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at risk for lower extremity amputation in a primary health care setting. Diabetes Care 1992;15:1386-1389.
46. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify the at risk patients for developing diabetic foot ulcers in a prospective multicenter trial. Diabetes Care. 2000;23:606-611.
47. Booth J, Young MJ. Differences in the performance of commercially available 10-g monofilaments. Diabetes Care. 2000;23:984-988.
48. Smieja M, Hunt DL, Edelman D, et al; International Cooperative Group for Clinical Examination Research. Clinical examination for the detection of protective sensation in the feet of diabetic patients. J Gen Intern Med. 1999;14:418-424.
49. Gerr FE, Letz R. Reliability of a widely used test of peripheral cutaneous vibration sensitivity and a comparison of two testing protocols. Br J Ind Med. 1988;45:635-639.
50. Rosenblum BI. Identifying the patient at risk of foot ulceration. Wounds. 2000;12(6 suppl B):7B-11B.
51. Mason J, O'Keeffe C, Hutchinson A, McIntosh A, Young R, Booth A. A systematic review of foot ulcer in patients with type 2 diabetes mellitus, II: treatment. Diabet Med. 1999;16:889-909.
52. Thivolet C. el Farkh J, Petiot A, Simonet C, Tourniaire J. Measuring vibration sensations with graduated tuning fork: simple and reliable means to detect diabetic patients at risk of neuropathic foot ulceration. Diabetes Care. 1990;13:1077-1080.
53. Liniger C, Albeanu A, Bloise D, Assal JP. The tuning fork revisited. Diabet Med. 1990;7:859-864.
54. Gin H, Rigalleau V, Baillet L, Rabemanantsoa C. Comparison between monofilament, tuning fork and vibration perception tests for screening patients at risk of foot complication. Diabetes Metab. 2002;28:457-461.
55. Coppini DV, Young PJ, Weng C, Macleod AF, Sonksen PH. Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: a case-control study. Diabet Med. 1998;15:765-771.
56. Pitei DL, Edmonds ME. Foot pressure measurements. Wounds. 2000;12(6 suppl B):19B-29B.
57. Armstrong DG, Peters EJ, Athanasiou KA, Lavery LA. Is there a critical level of plantar foot pressure to identify patients at risk for neuropathic foot ulceration? J Foot Ankle Surg. 1998;37:303-307.
58. Lavery LA, Armstrong DC, Wunderlich RP, Tredwell JL, Boulton AJM. Predictive value of foot pressure assessment as part of a population-based diabetes disease management program. Diabetes Care. 2003;26:1069-1073.
59. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26:3333-3341.
60. Kruger S, Guthrie D. Foot care: knowledge retention and self-care practices. Diabetes Educ. 1992;18:487-490.
61. Mazzuca SA, Moorman NH, Wheeler ML, et al. The diabetes education study: a controlled trial of the effects of diabetes patient education. Diabetes Care. 1986;9:1-10.
62. Barth R, Campbell LV, Allen S, Jupp JJ, Chisholm DJ. Intensive education improves knowledge, compliance, and foot problems in type 2 diabetes. Diabet Med. 1991;8:111-117.
63. Bloomgarden ZT, Karmally W, Metzger MJ, et al. Randomized, controlled trial of diabetic patient education: improved knowledge without improved metabolic status. Diabetes Care. 1987;10:263-272.
64. Litzelman DK, Slemenda CW, Langefeld CD, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: a randomized, controlled trial. Ann Intern Med. 1993;119:36-41.
65. Pieber TR, Holler A, Siebenhofer A, et al. Evaluation of a structured teaching and treatment programme for type 2 diabetes in general practice in a rural area of Austria. Diabet Med. 1995;12:349-354.
66. Malone JM, Snyder M, Anderson G, Bernhard VM, Holloway GA Jr, Bunt TJ. Prevention of amputation by diabetic education. Am J Surg. 1989;158:520-523.
67. Valk CD, Kriegsman DM, Assendelft WJ. Patient education for preventing diabetic foot ulceration: a systematic review. Endocrinol Metab Clin North Am. 2002;31:633-658.
68. Khoury A, Landers P, Roth M, et al. Computer-supported identification and intervention for diabetic patients at risk for amputation. MD Comput. 1998;15:307-310.
69. Wheatley C. Audit protocol: part one: prevention of diabetic foot ulcers - the non-complicated foot. J Clin Govern. 2001;9:93-100.
70. Bruckner M, Mangan M, Codin S, Pogach L. Project LEAP of New Jersey: lower extremity amputation prevention in persons with type 2 diabetes. Am J Manag Care. 1999;5:609-616.
71. Rith-Najarian S, Branchaud C, Beaulieu O, Gohdes D, Simonson G, Mazze R. Reducing lower-extremity amputations due to diabetes: application of the staged diabetes management approach in a primary care setting. J Fam Pract. 1998;47:127-132.
72. Frykberg RG, Armstrong DG, Giurini JM, et al. Diabetic foot disorders: a clinical practice guideline. J Foot Ankle Surg. 2000;39:S2-S60.
73. Hutchinson A, McIntosh A, Feder G, Home PD, Young R. Clinical Guidelines for Type 2 Diabetes: Prevention and Management of Foot Problems. London, England: Royal College of General Practitioners: 2000.
74. International Consensus on the Diabetic Foot: Practical Guidelines [book on CD-ROM]. Noordwijkerhout, the Netherlands: International Working Croup on the Diabetic Foot; 1999.
75. Supplement to the International Consensus on the Diabetic Foot: Practical Guidelines [book on CD-ROM]. Noordwijkerhout, the Netherlands: International Working Group on the Diabetic Foot; 2003.
76. US Veterans Health Administration/Department of Defense. Clinical Practice Guidelines: Diabetes Mellitus Algorithms - Module F: Foot Care. Washingon, DC: Veterans Health Administration; 2003.
77. American Diabetes Association. Preventative foot care in people with diabetes. Diabetes Care. 2004;27(suppl 1):S31-S32.
78. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. W Engl J Med. 1993;329:977-986.
79. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
80. Chaturvedi N, Abbott CA, Whalley A, Widdows P, Leggetter SY, Boulton AJ. Risk of diabetes-related amputation in South Asians vs Europeans in the UK. Diabet Med. 2002;19:99-104.
81. Jbour AS, Jarrah NS, Radaideh AM, et al. Prevalence and predictors of diabetic foot syndrome in type 2 diabetes mellitus in Jordan. Saudi Med J. 2003;24:761-764.
82. Mayfield JA, Reiber GE, Nelson RG, Greene T. Do foot examinations reduce the risk of diabetic amputation? J Fam Pract. 2000;49:499-504.
83. Ganiats TG. Judging the evidence for interventions: asking the right questions about foot examinations for patients with diabetes. J Fam Pract. 2000;49:505-506.
84. Plank J, Haas W, Rakovac I, et al. Evaluation of the impact of chiropodist care in the secondary prevention of foot ulcerations in diabetic subjects. Diabetes Care. 2003;26:1691-1695.
85. Tyrrell W. Orthotic intervention in patients with diabetic foot ulceration. J Wound Care. 1999;8:530-532.
86. Reiber GE, Smith DG, Wallace C, et al. Effect of therapeutic footwear on foot reulceration in patients with diabetes: a randomized controlled trial. JAMA. 2002;287:2552-2558.
87. Cavanagh PR, Boulton AJ, Sheehan P, Ulbrecht JS, Caputo GM, Armstrong DG. Therapeutic footwear in patients with diabetes. JAMA. 2002;288:1231.
88. Colagiuri S, Marsden LL, Naidu V, Taylor L. The use of orthotic devices to correct plantar callus in people with diabetes. Diabetes Res Clin Pract. 1995;28:29-34.
89. Uccioli L, Faglia E, Monticone G, et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care. 1995;18:1376-1378.
90. Busch K, Chantelau E. Effectiveness of a new brand of stock "diabetic" shoes to protect against diabetic foot ulcer relapse: a prospective cohort study. Diabet Med. 2003;20:665-669.
91. Young MJ, Cavanagh PR, Thomas G, Johnson MM, Murray H, Boulton AJ. The effect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabet Med. 1992;9:55-57.
92. Soulier SM, Godsey C, Asay ED, Perrotta DM. The prevention of plantar ulceration in the diabetic foot through the use of running shoes. Diabetes Educ. 1987;13:130-132.
93. Pitei DL, Foster A, Edmonds M. The effect of regular callus removal on foot pressures. J Foot Ankle Surg. 1999;38:251-255.
94. Ronnemaa T, Hamalainen H, Toikka T, Liukkonen I. Evaluation of the impact of podiatrist care in the primary prevention of foot problems in diabetic subjects. Diabetes Care. 1997;20:1833-1837.
95. van Putten M, Schaper NC. The preventive value of podiatry for the diabetic foot at risk for ulceration. Paper presented at: International Consensus on the Diabetic Foot; May 22-24, 2003; Noordwijkerhout, the Netherlands.
96. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system: the contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care. 1998;21:855-859.
97. Armstrong DG, Harkless LB. Outcomes of preventative care in a diabetic foot specialty clinic. J Foot Ankle Surg. 1998;37:460-466.
98. Wagner FW. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2:64-122.
99. Armstrong DG, Lavery LA, Stern S, Harkless LB. Is prophylactic diabetic foot surgery dangerous? J Foot Ankle Surg. 1996;35:585-589.
100. Armstrong DG, Stacpoole-Shea S, Nguyen HC, Harkless LB. Lengthening of the Achilles tendon in diabetic patients who are at high risk for ulceration of the foot. J Bone Joint Surg Am. 1999;81A:535-538.
101. Gudas CJ. Prophylactic surgery in the diabetic foot. Clin Podiatr Med Surg. 1987;4:445-458.
102. Catanzariti AR, Blitch EL, Karlock LG. Elective foot and ankle surgery in the diabetic patient. J Foot Ankle Surg. 1995;34:23-41.
103. Simon SR, Tejwani SG, Wilson DL, Santner TJ, Denniston NL. Arthrodesis as an early alternative to nonoperative management of charcot arthropathy of the diabetic foot. J Bone Joint Surg Am. 2000;82-A: 939-950.
104. Rosenblum BI, Giurini JM, Chrzan JS, Habershaw GM. Preventing loss of the great toe with the hallux interphalangeal arthroplasty. J Foot Ankle Surg. 1994;33:557-566.
105. Wieman TJ, Mercke YK, Cerrito PB, Taber SW. Resection of the metatarsal head for diabetic foot ulcers. Am J Surg. 1998;176:436-441.
106. Giurini JM, Basile P, Chrzan JS, Habershaw GM, Rosenblum BI. Panmetatarsal head resection: a viable alternative to the transmetatarsal amputation. J Am Podiatr Med Assoc. 1993;83:101-107.
107. Barry DC, Sabacinski KA, Habershaw GM, Giurini JM, Chrzan JS. Tendo Achillis procedures for chronic ulcerations in diabetic patients with transmetatarsal amputations. J Am Podiatr Med Assoc. 1993;83:96-100.
108. Giurini JM, Chrzan JS, Gibbons GW, Habershaw GM. Sesamoidectomy for the treatment of chronic reuropathic ulcerations. J Am Podiatr Med Assoc. 1991;81:167-173.
109. Fleischli JE, Anderson RB, Davis WH. Dorsiflexion metatarsal osteotomy for treatment of recalcitrant diabetic neuropathic ulcers. Foot Ankle Int. 1999;20:80-85.
110. Blume PA, Paragas LK, Sumpio BE, Attinger CE. Single-stage surgical treatment of noninfected diabetic foot ulcers. Plast Reconstr Surg. 2002;109:601-609.
111. Armstrong DG, Todd WF, Lavery LA, Harkless LB. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabet Med. 1997; 14:357-363.
112. Ha Van G, Siney H, Danan JP, Sachon C, Grimaldi A. Treatment of osteomyelitis in the diabetic foot: contribution of conservative surgery. Diabetes Care. 1996;19:1257-1260.
113. Scher KS, Steele FJ. The septic foot in patients with diabetes. Surgery. 1988;104:661-666.
114. Armstrong DG, Frykberg RG. Classification of diabetic foot surgery: toward a rational definition. Diabet Med. 2003;20:329-331.
115. Lin SS, Lee TH, Wapner KL. Plantar forefoot ulceration with equinus deformity of the ankle in diabetic patients: the effect of tendo-achilles lengthening and total contact casting. Orthopedics. 1996;19:465-475.
116. Mueller MJ, Sinacore DR, Hastings MK, Strube MJ, Johnson JE. Effect of achilles tendon lengthening on neuropathic plantar ulcers: a randomized clinical trial. J Bone Joint Surg Am. 2003;85-A:1436-1445.
117. Mueller MJ, Sinacore DR, Hastings MK, Lott DJ, Strube MJ, Johnson JE. Impact of achilles tendon lengthening on functional limitations and perceived disability in people with a neuropathic plantar ulcer. Diabetes Care. 2004;27:1559-1564.
118. Piaggesi A, Schipani E, Campi F, et al. Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial. Diabet Med. 1998;15:412-417.
119. Armstrong DG, Lavery LA, Vazquez JR, et al. Clinical efficacy of the first metatarsophalangeal joint arthroplasty as a curative procedure for hallux interphalangeal joint wounds in persons with diabetes. Diabetes Care. 2003;26:3284-3287.
120. Wang JC, Le AW, Tsukuda RK. A new technique for Charcot's foot reconstruction. J Am Podiatr Med Assoc. 2002;92:429-436.
121. Feinglass J, Brown JL, LoSasso A, et al. Rates of lower-extremity amputation and arterial reconstruction in the United States, 1979 to 1996. Am J Public Health. 1999;89:1222-1227.
122. Sumpio BE, Lee T, Blume PA. Vascular evaluation and arterial reconstruction of the diabetic foot. Clin Podiatr Med Surg. 2003;20:689-708.
123. Faglia E, Mantero M, Caminiti M, et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med. 2002;252:225-232.
124. Rauwerda JA. Surgical treatment of the infected diabetic foot. Diabetes Metab Res Rev. 2004;20(suppl 1):S41-S44.
125. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care. 2003;26:1790-1795.
126. Ragnarson Tennvall G, Apelqvist J. Health-economic consequences of diabetic foot lesions. Clin Infect Dis. 2004;39(suppl 2):S132-S139.
127. Ragnarson Tennvall G, Apelqvist J. Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia. 2001;44:2077-2087.
128. Ortegon MM, Redekop WK, Niessen LW. Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis. Diabetes Care. 2004;27:901-907.